Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.4
Consolidated Balance Sheets - USD ($)
Dec. 31, 2020
Dec. 31, 2019
CURRENT ASSETS    
Cash $ 19,229,232 $ 1,232,030
Prepaid expenses & other current assets 1,007,690 788
Total current assets 20,236,922 1,232,818
Property and equipment, net 21,507 8,758
Deferred offering costs 101,205 191,000
TOTAL ASSETS 20,359,634 1,432,576
CURRENT LIABILITIES    
Accounts payable and accrued expenses 552,339 489,292
Total Current Liabilities 552,339 489,292
PPP loan payable 108,500
TOTAL LIABILITIES 660,839 489,292
COMMITMENTS AND CONTINGENCIES (NOTE 5)
STOCKHOLDERS’ EQUITY    
Series A Preferred Stock (1,000,000 authorized at December 31, 2020; 3,480,000 authorized at December 31, 2019; $.0001 par value) (Zero shares issued and outstanding at December 31, 2020; 2,438,866 shares issued and outstanding at December 31, 2019) 244
Common Stock (25,000,000 authorized at December 31, 2020; 12,180,000 authorized at December 31, 2019; $.0001 par value) (6,220,927 shares issued and outstanding at December 31, 2020; 1,978,269 shares issued and outstanding at December 31, 2019) 622 198
Additional paid-in capital 32,358,068 7,694,547
Accumulated deficit (12,659,895) (6,751,705)
Total stockholders’ equity 19,698,795 943,284
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 20,359,634 $ 1,432,576